SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Progenitor (PGEN) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (84)4/30/1998 11:56:00 AM
From: Czechsinthemail  Read Replies (1) | Respond to of 106
 
I don't know how much effect it is likely to have on PGEN, but IPIC is up significantly on a positive news announcement. Here's the report from Briefing.com:

11:24 ET Interneuron Pharmaceutic (IPIC) 7 1/16 +1: Stock has surged out of negative territory on news the company has licensed Neurpeptide from Tulane University. Says drug has potential to treat stroke. Volume 687K.